|
|
Volumn 96, Issue 1, 2002, Pages 85-90
|
|
An economic comparison of chloroquine and sulfadoxine-pyrimethamine as first-line treatment for malaria in South Africa: Development of a model for estimating recurrent direct costs
a a a a |
|
Author keywords
Chemotherapy; Chloroquine; Cost effectiveness; Malaria; Modelling; Pharmacoeconomics; Plasmodium falciparum; South Africa; Sulfadoxine pyrimethamine
|
|
Indexed keywords
ANTIMALARIAL AGENT;
CHLOROQUINE;
FANSIDAR;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
COST UTILITY ANALYSIS;
DRUG COST;
DRUG EFFICACY;
HEALTH CARE COST;
HEALTH CARE PERSONNEL;
HEALTH CARE POLICY;
HUMAN;
IMMUNITY;
IN VIVO STUDY;
KENYA;
MAINTENANCE THERAPY;
MALARIA;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
MODEL;
MONTE CARLO METHOD;
PATIENT COMPLIANCE;
PATIENT TRANSPORT;
PLASMODIUM FALCIPARUM;
POPULATION RESEARCH;
PUBLIC HEALTH SERVICE;
SIDE EFFECT;
SOUTH AFRICA;
TIME;
TRAINING;
UGANDA;
ADULT;
ANTIMALARIALS;
CHLOROQUINE;
COST-BENEFIT ANALYSIS;
DECISION TREES;
DRUG COMBINATIONS;
DRUG COSTS;
HUMANS;
MALARIA, FALCIPARUM;
MODELS, ECONOMIC;
PYRIMETHAMINE;
SOUTH AFRICA;
SULFADOXINE;
ACER;
PLASMODIUM FALCIPARUM;
PROTOZOA;
|
|
EID: 0036322682
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/S0035-9203(02)90251-8 Document Type: Article |
|
Times cited : (9)
|
|
References (16)
|
